Table 1.
An aetiological classification of HUS (see [1]). HELLP haemolysis, elevated liver enzymes, low platelets
Category | Characteristics |
---|---|
Level 1: aetiology advanced | |
1.i | Infection induced |
(a) Shiga and shiga-like toxin-producing bacteria; enterohaemorrhagic Escherichia coli, Shigella dysenteriae type 1, Citrobacter freundii | |
(b) Streptococcus pneumoniae, neuraminidase and T-antigen exposure | |
1.ii | Disorders of complement regulation |
(a) Genetic disorders of complement regulation | |
(b) Acquired disorders of complement regulation, e.g. anti-factor H antibody | |
1.iii | von Willebrand proteinase, ADAMTS13, deficiency |
(a) Genetic disorders of ADAMTS13 | |
(b) Acquired ADAMTS13 deficiency; autoimmune, drug induced | |
1.iv | Defective cobalamin metabolism |
1.v | Quinine induced |
Level 2: aetiology unknown | |
2.i | Human immunodeficiency virus (HIV) |
2.ii | Malignancy, cancer chemotherapy and ionising radiation |
2.iii | Calcineurin inhibitors and transplantation |
2.iv | Pregnancy, HELLP syndrome and oral contraceptive pill |
2.v | Systemic lupus erythematosus and antiphospholipid antibody syndrome |
2 vi | Glomerulopathy |
2.vii | Familial, not included in part 1 |
2.viii | Unclassified |